Loading…
Reported covered position: Legislative Director, Rep. Artur Davis; Legislative Assistant, Rep. Tom Barrett
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Medicare IVIG Access Enhancement Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donotions.
Medicare IVIG Access Enhancement Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2022 · first_quarter · Q1
Education visits to House and Senate offices relating to plasma protein therapies and the rare disease patients that use them and the economic value as well as the need for continued Source plasma donations. The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD. CMS programs relating to proposed rules, including most favored nation and international pricing index and use of foreign reference pricing. HCR that moves U.S. towards single decisionmakers and government negotiations. HR 3 Lowering Drug Costs Now Act provisions relating to drug reimbursement in Medicare and the Build Back Better Act provisions related to drug pricing. . Issues relating to COVID and plasma protein products and 116th Congress "Plasma Donation Awareness Act" and reintroduction in 117th Congress. Activity related to cross border donation of plasma and impact on patients.
Source: Senate LDA
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donotions.
Medicare IVIG Access Enhancement Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing.
Medicare IVIG Access Enhancement Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donations. Issues relating to enactment of HR 7839, extension of the IVIG Demonstration project.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donations. Issues relating to enactment of HR 7839, extension of the IVIG Demonstration project.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donotions.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donotions.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing.
Continuing Access to In-Home IVIG Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donations. Issues relating to enactment of HR 7839, extension of the IVIG Demonstration project.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy. Availability of plasma protein products, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donations.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy. Availability of plasma protein products, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy. Availability of plasma protein products, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donations. Issues relating to Covid-19 vaccine priorities for donation center workers.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy. Availability of plasma protein products, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donations.
Medicare IVIG Access Enhancement Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donotions.
Medicare IVIG Access Enhancement Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donations. Issues relating to enactment of HR 7839, extension of the IVIG Demonstration project.
Medicare IVIG Access Enhancement Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing.
Medicare IVIG Access Enhancement Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donotions.
Medicare IVIG Access Enhancement Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS.
Medicare IVIG Access Enhancement Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy.
Medicare Part B Home Infusion Services Temporary Transitional Payment Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Medicare Part B Home Infusion Services Temporary Transitional Payment Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Safe Students Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Safe Students Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Medicare IVIG Access Enhancement Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs.
Medicare IVIG Access Enhancement Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Medicare IVIG Access Enhancement Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Medicare IVIG Access Enhancement Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS.
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD and H.R. 3808. CMS programs relating to proposed rules, including most favored nation and international pricing index. HR 3 Lowering Drug Costs Now Act provisions relating to drug reimbursement in Medicare and HR 5376 Build Back Better Act provisions related to drug pricing. Issues relating to COVID and plasma protein products and 116th Congress "Plasma Donation Awareness Act" and reintroduction in 117th Congress. Activity relating to cross border donation of plasma.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS)
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2021 · fourth_quarter · Q4
Education visits to House and Senate offices relating to plasma protein therapies and the rare disease patients that use them and the economic value as well as the need for continued Source plasma donations. The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD. CMS programs relating to proposed rules, including most favored nation and international pricing index and use of foreign reference pricing. HCR that moves U.S. towards single decisionmakers and government negotiations. HR 3 Lowering Drug Costs Now Act provisions relating to drug reimbursement in Medicare and the Build Back Better Act provisions related to drug pricing. . Issues relating to COVID and plasma protein products and 116th Congress "Plasma Donation Awareness Act" and reintroduction in 117th Congress. Activity related to cross border donation of plasma and impact on patients.
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD and H.R. 3808. CMS programs relating to proposed rules, including most favored nation and international pricing index. HR 3 Lowering Drug Costs Now Act provisions relating to drug reimbursement in Medicare and HR 5376 Build Back Better Act provisions related to drug pricing. Issues relating to COVID and plasma protein products and 116th Congress "Plasma Donation Awareness Act" and reintroduction in 117th Congress. Activity relating to cross border donation of plasma.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS)
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2021 · third_quarter · Q3
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD and H.R. 3808. CMS programs relating to proposed rules, including most favored nation and international pricing index. HR 3 Lowering Drug Costs Now Act provisions relating to drug reimbursement in Medicare. Issues relating to COVID and plasma protein products and 116th Congress "Plasma Donation Awareness Act" and reintroduction in 117th Congress. Activity relating to cross border donation of plasma.
Education visits to House and Senate offices relating to plasma protein therapies and the rare disease patients that use them and the economic value as well as the need for continued Source plasma donations. The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD. CMS programs relating to proposed rules, including most favored nation and international pricing index and use of foreign reference pricing. HCR that moves U.S. towards single decisionmakers and government negotiations. HR 3 Lowering Drug Costs Now Act provisions relating to drug reimbursement in Medicare. Issues relating to COVID and plasma protein products and 116th Congress "Plasma Donation Awareness Act" and reintroduction in 117th Congress. Activity related to cross border donation of plasma and impact on patients.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS)
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2021 · second_quarter · Q2
Education visits to House and Senate offices relating to plasma protein therapies and the rare disease patients that use them and the economic value as well as the need for continued Source plasma donations. The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD. CMS programs relating to proposed rules, including most favored nation and international pricing index and use of foreign reference pricing. HCR that moves U.S. towards single decisionmakers and government negotiations. HR 3 Lowering Drug Costs Now Act provisions relating to drug reimbursement in Medicare. Issues relating to COVID and plasma protein products and 116th Congress "Plasma Donation Awareness Act" and reintroduction in 117th Congress. Activity related to cross border donation of plasma and impact on patients.
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD. CMS programs relating to proposed rules, including most favored nation and international pricing index. HR 3 Lowering Drug Costs Now Act provisions relating to drug reimbursement in Medicare. Issues relating to COVID and plasma protein products and 116th Congress "Plasma Donation Awareness Act" and reintroduction in 117th Congress. Activity relating to cross border donation of plasma.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2021 · first_quarter · Q1
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD. CMS programs relating to proposed rules, including most favored nation and international pricing index. HR 3 Lowering Drug Costs Now Act provisions relating to drug reimbursement in Medicare. Issues relating to COVID and plasma protein products and 116th Congress "Plasma Donation Awareness Act" and reintroduction in 117th Congress.
Education visits to House and Senate offices relating to plasma protein therapies and the rare disease patients that use them and the economic value as well as the need for continued Source plasma donations. The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD. CMS programs relating to proposed rules, including most favored nation and international pricing index and use of foreign reference pricing. HCR that moves U.S. towards single decisionmakers and government negotiations. HR 3 Lowering Drug Costs Now Act provisions relating to drug reimbursement in Medicare. Issues relating to COVID and plasma protein products and 116th Congress "Plasma Donation Awareness Act" and reintroduction in 117th Congress.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2020 · fourth_quarter · Q4
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy. Availability of plasma protein products, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donations. Issues relating to Covid-19 vaccine priorities for donation center workers.
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donations. Issues relating to enactment of HR 7839, extension of the IVIG Demonstration project.
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2020 · third_quarter · Q3
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy. Availability of plasma protein products, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donations.
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donotions.
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2020 · second_quarter · Q2
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy. Availability of plasma protein products, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donations.
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing and plasma center donotions.
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2020 · first_quarter · Q1
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy. Availability of plasma protein products, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing.
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS, specifically home infusion of plasma protein products during the Covid-19 pandemic. Issues relating to availability of plasma donation center testing.
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2019 · fourth_quarter · Q4
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy.
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs. Issues relating to access of plasma protein products by HHS and CMS.
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2019 · third_quarter · Q3
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees, HR 2905, Medicare IVIG Enhancement Act relating to payment for immunoglobulin for home infusion, H.R. 3 - Lower Drug Costs Now Act of 2019, sections relating to drug reimbursement and pricing programs.
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2019 · second_quarter · Q2
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy.
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2019 · first_quarter · Q1
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy.
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE